Status:
UNKNOWN
Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal Hypertension
Lead Sponsor:
Hepatopancreatobiliary Surgery Institute of Gansu Province
Collaborating Sponsors:
LanZhou University
Lishui hospital of Zhejiang University
Conditions:
Liver Cirrhosis
Portal Hypertension
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Portal hypertension is a common complication of chronic liver disease and is associated with most clinical consequences of cirrhosis. The most reliable method for assessing portal hypertension is the ...
Detailed Description
Portal hypertension is a common complication of chronic liver disease and is associated with most clinical consequences of cirrhosis. The most reliable method for assessing portal hypertension is the ...
Eligibility Criteria
Inclusion
- Patients with cirrhosis and portal hypertension undergoing elective TIPS placement
- ASAⅠ\~Ⅲ
Exclusion
- Patients with portal vein thrombosis and vein-to-vein communications
- Refusal of consent
- Presence of allergy to fentanyl
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04724148
Start Date
January 1 2022
End Date
November 1 2024
Last Update
April 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Hospital of Lanzhou University
Lanzhou, Gansu, China, 730000